Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jasper Therapeutics, Inc. (JSPR) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jasper Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1788028.
Total stock buying since 2020: $15,717,628.
Total stock sales since 2020: $1,121,376.
Total stock option exercises since 2020: $31,950.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 540,000 | $6,993,000 | 3,600 | $84,533 | 3,600 | $25,560 |
| 2023 | 5,839,999 | $8,724,628 | 116,540 | $199,562 | 9,000 | $6,390 |
| 2022 | 0 | $0 | 49,486 | $101,445 | 0 | $0 |
| 2021 | 0 | $0 | 25,183 | $260,297 | 9,200,000 | $0 |
| 2020 | 0 | $0 | 47,006 | $475,539 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 0 | $0 | 900 | $19,899 | 900 | $6,390 |
| 2024-09 | 0 | $0 | 900 | $19,103 | 900 | $6,390 |
| 2024-06 | 0 | $0 | 900 | $21,739 | 900 | $6,390 |
| 2024-03 | 0 | $0 | 900 | $23,792 | 900 | $6,390 |
| 2024-02 | 540,000 | $6,993,000 | 0 | $0 | 0 | $0 |
| 2023-11 | 40,000 | $24,630 | 0 | $0 | 0 | $0 |
| 2023-10 | 0 | $0 | 7,965 | $6,778 | 0 | $0 |
| 2023-06 | 0 | $0 | 9,000 | $14,913 | 9,000 | $6,390 |
| 2023-04 | 0 | $0 | 24,575 | $36,121 | 0 | $0 |
| 2023-01 | 5,799,999 | $8,699,998 | 75,000 | $141,750 | 0 | $0 |
| 2022-06 | 0 | $0 | 49,486 | $101,445 | 0 | $0 |
| 2021-09 | 0 | $0 | 0 | $0 | 9,200,000 | $0 |
| 2021-04 | 0 | $0 | 2,060 | $20,538 | 0 | $0 |
| 2021-02 | 0 | $0 | 13,022 | $136,209 | 0 | $0 |
| 2021-01 | 0 | $0 | 10,101 | $103,550 | 0 | $0 |
| 2020-12 | 0 | $0 | 40,094 | $406,462 | 0 | $0 |
| 2020-09 | 0 | $0 | 3,514 | $35,131 | 0 | $0 |
| 2020-08 | 0 | $0 | 3,398 | $33,946 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Sale | 900 | 22.11 | 19,899 |
| 2024-12-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Option Ex | 900 | 7.10 | 6,390 |
| 2024-09-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Sale | 900 | 21.23 | 19,103 |
| 2024-09-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Option Ex | 900 | 7.10 | 6,390 |
| 2024-06-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Sale | 900 | 24.16 | 21,739 |
| 2024-06-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Option Ex | 900 | 7.10 | 6,390 |
| 2024-03-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Sale | 900 | 26.44 | 23,792 |
| 2024-03-12 | Mahal Jeetinder Singh (Chief Operating Officer) | Option Ex | 900 | 7.10 | 6,390 |
| 2024-02-08 | Morgan Adam | Buy | 350,000 | 12.95 | 4,532,500 |
| 2024-02-08 | Abingworth Bioventures Vii Lp | Buy | 190,000 | 12.95 | 2,460,500 |
| 2023-11-21 | Wiggans Thomas G | Buy | 10,000 | .64 | 6,380 |
| 2023-11-20 | Wiggans Thomas G | Buy | 10,000 | .63 | 6,310 |
| 2023-11-17 | Wiggans Thomas G | Buy | 10,000 | .60 | 5,970 |
| 2023-11-16 | Wiggans Thomas G | Buy | 10,000 | .60 | 5,970 |
| 2023-10-13 | Lis William | Sale | 7,965 | .85 | 6,778 |
| 2023-06-13 | Mahal Jeetinder Singh (See Remarks) | Sale | 9,000 | 1.66 | 14,913 |
| 2023-06-13 | Mahal Jeetinder Singh (See Remarks) | Option Ex | 9,000 | .71 | 6,390 |
| 2023-04-14 | French Anna Louise | Sale | 7,000 | 1.48 | 10,360 |
| 2023-04-13 | Lis William | Sale | 8,500 | 1.44 | 12,240 |
| 2023-04-13 | Emster Kurt Von | Sale | 9,075 | 1.49 | 13,521 |
| 2023-01-27 | Carlyle Genesis Uk Llc (10% Owner) | Buy | 3,133,333 | 1.50 | 4,699,999 |
| 2023-01-27 | Rieschel Gary E (10% Owner) | Buy | 2,666,666 | 1.50 | 3,999,999 |
| 2023-01-25 | Roche Finance Ltd | Sale | 75,000 | 1.89 | 141,750 |
| 2022-06-27 | Lis William | Sale | 24,743 | 2.08 | 51,415 |
| 2022-06-24 | Lis William | Sale | 24,743 | 2.02 | 50,030 |
| 2021-09-24 | Amplitude Healthcare Holdings Llc | Option Ex | 2,300,000 | .00 | 0 |
| 2021-09-24 | Clifford Kenneth F | Option Ex | 2,300,000 | .00 | 0 |
| 2021-09-24 | Hoffen Howard I | Option Ex | 2,300,000 | .00 | 0 |
| 2021-09-24 | Venkataraman Balaji | Option Ex | 2,300,000 | .00 | 0 |
| 2021-04-19 | Glazer Paul J (10% Owner) | Sale | 2,060 | 9.97 | 20,538 |
| 2021-02-22 | Glazer Paul J (10% Owner) | Sale | 698 | 10.50 | 7,329 |
| 2021-02-19 | Glazer Paul J (10% Owner) | Sale | 2,112 | 10.50 | 22,176 |
| 2021-02-18 | Glazer Paul J (10% Owner) | Sale | 10,000 | 10.45 | 104,500 |
| 2021-02-05 | Glazer Paul J (10% Owner) | Sale | 212 | 10.40 | 2,204 |
| 2021-01-14 | Glazer Paul J (10% Owner) | Sale | 101 | 10.40 | 1,050 |
| 2021-01-08 | Glazer Paul J (10% Owner) | Sale | 10,000 | 10.25 | 102,500 |
| 2020-12-30 | Glazer Paul J (10% Owner) | Sale | 75 | 10.25 | 768 |
| 2020-12-29 | Glazer Paul J (10% Owner) | Sale | 18 | 10.25 | 184 |
| 2020-12-28 | Glazer Paul J (10% Owner) | Sale | 10,000 | 10.20 | 102,000 |
| 2020-12-22 | Glazer Paul J (10% Owner) | Sale | 10,000 | 10.15 | 101,500 |
| 2020-12-15 | Glazer Paul J (10% Owner) | Sale | 10,000 | 10.15 | 101,500 |
| 2020-12-14 | Glazer Paul J (10% Owner) | Sale | 5,000 | 10.05 | 50,250 |
| 2020-12-11 | Glazer Paul J (10% Owner) | Sale | 5,000 | 10.05 | 50,250 |
| 2020-12-07 | Glazer Paul J (10% Owner) | Sale | 1 | 10.05 | 10 |
| 2020-09-21 | Glazer Paul J (10% Owner) | Sale | 1,000 | 10.00 | 10,000 |
| 2020-09-18 | Glazer Paul J (10% Owner) | Sale | 1,000 | 10.00 | 10,000 |
| 2020-09-16 | Glazer Paul J (10% Owner) | Sale | 20 | 9.99 | 199 |
| 2020-09-15 | Glazer Paul J (10% Owner) | Sale | 800 | 9.99 | 7,992 |
| 2020-09-11 | Glazer Paul J (10% Owner) | Sale | 682 | 9.99 | 6,813 |
| 2020-09-08 | Glazer Paul J (10% Owner) | Sale | 1 | 9.99 | 9 |
| 2020-09-04 | Glazer Paul J (10% Owner) | Sale | 11 | 10.73 | 118 |
| 2020-08-17 | Glazer Paul J (10% Owner) | Sale | 1,699 | 9.99 | 16,973 |
| 2020-08-13 | Glazer Paul J (10% Owner) | Sale | 1,699 | 9.99 | 16,973 |
Insider trading activities including stock purchases, stock sales, and option exercises of JSPR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jasper Therapeutics, Inc. (symbol JSPR, CIK number 1788028) see the Securities and Exchange Commission (SEC) website.